Charles Schwab’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4M | Buy |
4,970,895
+31,319
| +0.6% | +$72K | ﹤0.01% | 1948 |
|
|
2025
Q1 | $21.4M | Buy |
4,939,576
+398,027
| +9% | +$1.72M | ﹤0.01% | 1606 |
|
|
2024
Q4 | $8.63M | Buy |
4,541,549
+1,498,524
| +49% | +$2.85M | ﹤0.01% | 2080 |
|
|
2024
Q3 | $12M | Sell |
3,043,025
-171,360
| -5% | -$673K | ﹤0.01% | 1946 |
|
|
2024
Q2 | $21M | Buy |
3,214,385
+1,007,555
| +46% | +$6.59M | ﹤0.01% | 1651 |
|
|
2024
Q1 | $13.5M | Buy |
2,206,830
+360,188
| +20% | +$2.2M | ﹤0.01% | 1829 |
|
|
2023
Q4 | $23.2M | Buy |
1,846,642
+49,758
| +3% | +$624K | 0.01% | 1498 |
|
|
2023
Q3 | $31.9M | Buy |
1,796,884
+70,443
| +4% | +$1.25M | 0.01% | 1184 |
|
|
2023
Q2 | $29.9M | Buy |
1,726,441
+557,237
| +48% | +$9.66M | 0.01% | 1215 |
|
|
2023
Q1 | $27.8M | Buy |
1,169,204
+10,606
| +0.9% | +$252K | 0.01% | 1218 |
|
|
2022
Q4 | $18.7M | Buy |
1,158,598
+52,002
| +5% | +$839K | 0.01% | 1495 |
|
|
2022
Q3 | $25.9M | Buy |
1,106,596
+818,132
| +284% | +$19.2M | 0.01% | 1191 |
|
|
2022
Q2 | $6.3M | Buy |
288,464
+13,514
| +5% | +$295K | ﹤0.01% | 2086 |
|
|
2022
Q1 | $6.97M | Buy |
274,950
+7,568
| +3% | +$192K | ﹤0.01% | 2116 |
|
|
2021
Q4 | $7.22M | Buy |
267,382
+18,837
| +8% | +$509K | ﹤0.01% | 2167 |
|
|
2021
Q3 | $6.52M | Buy |
248,545
+26,138
| +12% | +$685K | ﹤0.01% | 2246 |
|
|
2021
Q2 | $9.02M | Buy |
+222,407
| New | +$9.02M | ﹤0.01% | 2057 |
|